Skip Navigation


Human Molecular Genetics Advance Access originally published online on October 21, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
12/24/3259    most recent
ddg357v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (76)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Li, Y.-J.
Right arrow Articles by Pericak-Vance, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.-J.
Right arrow Articles by Pericak-Vance, M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 24 3259-3267
DOI: 10.1093/hmg/ddg357
© 2003 Oxford University Press

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease

Yi-Ju Li1,*,{dagger}, Sofia A. Oliveira1,{dagger}, Puting Xu1, Eden R. Martin1, Judith E. Stenger1, Clemens R. Scherzer2, Michael A. Hauser1, William K. Scott1, Gary W. Small3, Martha A. Nance4, Ray L. Watts5, Jean P. Hubble6, William C. Koller7, Rajesh Pahwa8, Mathew B. Stern9, Bradley C. Hiner10, Joseph Jankovic11, Christopher G. Goetz12, Frank Mastaglia13, Lefkos T. Middleton14, Allen D. Roses15, Ann M. Saunders15, Donald E. Schmechel16, Steven R. Gullans2, Jonathan L. Haines17,{ddagger}, John R. Gilbert1,{ddagger}, Jeffery M. Vance1,{ddagger} and Margaret A. Pericak-Vance1,{ddagger}

1Department of Medicine and Center for Human Genetics, Duke University Medical Center, Durham, NC 27710, USA, 2Harvard University Medical School, Boston, MA 02115, USA, 3Departments of Psychiatry and Biobehavioral Science and Neurology, University of California, Los Angeles, CA 90024, USA, 4Struthers Parkinson Center, Golden Valley, MN 55426, USA, 5Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA, 6Department of Neurology, Ohio State University, Columbus, OH 43210, USA, 7Department of Neurology, University of Miami School of Medicine, Miami, FL 33124, USA, 8Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66045, USA, 9Department of Neurology, University of Pennsylvania Health System, Philadelphia, PA 19104, USA, 10Department of Neurology, Marshfield Clinic, Marshfield, WI 54449, USA, 11Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA, 12Department of Neurological Sciences, Rush-Presbyterian–St Luke's Hospital, Chicago, IL 60612, USA, 13Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Perth, Western Australia 6009, Australia, 14GlaxoSmithKline Research and Development, Greenford, Middlesex UB6 0HE, UK, 15GlaxoSmithKline Genetics Research Directorate, Research Triangle Park, NC, USA, 16Department of Medicine and Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, NC 27710, USA and 17Program in Human Genetics, Vanderbilt University Medical Center, Nashville, TN 37232, USA

Received July 7, 2003; Revised September 22, 2003; Accepted September 29, 2003

We previously reported genetic linkage of loci controlling age-at-onset in Alzheimer disease (AD) and Parkinson's disease (PD) to a 15 cM region on chromosome 10q. Given the large number of genes in this initial starting region, we applied the process of ‘genomic convergence’ to prioritize and reduce the number of candidate genes for further analysis. As our second convergence factor we performed gene expression studies on hippocampus obtained from AD patients and controls. Analysis revealed that four of the genes [stearoyl-CoA desaturase; NADH-ubiquinone oxidoreductase 1 beta subcomplex 8; protease, serine 11; and glutathione S-transferase, omega-1 (GSTO1)] were significantly different in their expression between AD and controls and mapped to the 10q age-at-onset linkage region, the first convergence factor. Using 2814 samples from our AD dataset (1773 AD patients) and 1362 samples from our PD dataset (635 PD patients), allelic association studies for age-at-onset effects in AD and PD revealed no association for three of the candidates, but a significant association was found for GSTO1 (P=0.007) and a second transcribed member of the GST omega class, GSTO2 (P=0.005), located next to GSTO1. The functions of GSTO1 and GSTO2 are not well understood, but recent data suggest that GSTO1 maybe involved in the post-translational modification of the inflammatory cytokine interleukin-1ß. This is provocative given reports of the possible role of inflammation in these two neurodegenerative disorders.

* To whom correspondence should be addressed at: Center for Human Genetics, Institute for Genome Science and Policy, Duke University Medical Center Box 3445, Durham, NC 27710, USA. Tel: +1 9196840604; Fax: +1 9196840921; Email: yiju.li{at}duke.edu

{dagger} These authors contributed equally to the manuscript.

{ddagger} These authors contributed equally to the manuscript.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Respir JHome page
S. Sharma, A. J. Murphy, M. E. Soto-Quiros, L. Avila, B. J. Klanderman, J. S. Sylvia, J. C. Celedon, B. A. Raby, and S. T. Weiss
Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness
Eur. Respir. J., June 1, 2009; 33(6): 1287 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. H. Lee, R. Cheng, N. Graff-Radford, T. Foroud, R. Mayeux, and for the National Institute on Aging Late-Onset Alz
Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: Implication of Additional Loci
Arch Neurol, November 1, 2008; 65(11): 1518 - 1526.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Chapuis, F. Moisan, G. Mellick, A. Elbaz, P. Silburn, F. Pasquier, D. Hannequin, C. Lendon, D. Campion, P. Amouyel, et al.
Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease
Hum. Mol. Genet., September 15, 2008; 17(18): 2863 - 2867.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
A. B. Conley, J. Piriyapongsa, and I. K. Jordan
Retroviral promoters in the human genome
Bioinformatics, July 15, 2008; 24(14): 1563 - 1567.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
C. Burmeister, K. Luersen, A. Heinick, A. Hussein, M. Domagalski, R. D. Walter, and E. Liebau
Oxidative stress in Caenorhabditis elegans: protective effects of the Omega class glutathione transferase (GSTO-1)
FASEB J, February 1, 2008; 22(2): 343 - 354.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J. A. Calarco, Y. Xing, M. Caceres, J. P. Calarco, X. Xiao, Q. Pan, C. Lee, T. M. Preuss, and B. J. Blencowe
Global analysis of alternative splicing differences between humans and chimpanzees
Genes & Dev., November 15, 2007; 21(22): 2963 - 2975.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Konings, L. Van Laer, M. Pawelczyk, P.-I. Carlsson, M.-L. Bondeson, E. Rajkowska, A. Dudarewicz, A. Vandevelde, E. Fransen, J. Huyghe, et al.
Association between variations in CAT and noise-induced hearing loss in two independent noise-exposed populations
Hum. Mol. Genet., August 1, 2007; 16(15): 1872 - 1883.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. H. Lee, R. Cheng, V. Santana, J. Williamson, R. Lantigua, M. Medrano, A. Arriaga, Y. Stern, B. Tycko, E. Rogaeva, et al.
Expanded Genomewide Scan Implicates a Novel Locus at 3q28 Among Caribbean Hispanics With Familial Alzheimer Disease
Arch Neurol, November 1, 2006; 63(11): 1591 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. Kuwano, A. Miyashita, H. Arai, T. Asada, M. Imagawa, M. Shoji, S. Higuchi, K. Urakami, A. Kakita, H. Takahashi, et al.
Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease
Hum. Mol. Genet., July 1, 2006; 15(13): 2170 - 2182.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Karamohamed, J. C. Latourelle, B. A. Racette, J. S. Perlmutter, G. F. Wooten, M. Lew, C. Klein, H. Shill, L. I. Golbe, M. H. Mark, et al.
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study
Neurology, December 13, 2005; 65(11): 1823 - 1825.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
E R Martin, P G Bronson, Y-J Li, N Wall, R-H Chung, D E Schmechel, G Small, P-T Xu, J Bartlett, N Schnetz-Boutaud, et al.
Interaction between the {alpha}-T catenin gene (VR22) and APOE in Alzheimer's disease
J. Med. Genet., October 1, 2005; 42(10): 787 - 792.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. C. David, S. Hauptmann, I. Scherping, K. Schuessel, U. Keil, P. Rizzu, R. Ravid, S. Drose, U. Brandt, W. E. Muller, et al.
Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice
J. Biol. Chem., June 24, 2005; 280(25): 23802 - 23814.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. A. Hauser, Y.-J. Li, H. Xu, M. A. Noureddine, Y. S. Shao, S. R. Gullans, C. R. Scherzer, R. V. Jensen, A. C. McLaurin, J. R. Gibson, et al.
Expression Profiling of Substantia Nigra in Parkinson Disease, Progressive Supranuclear Palsy, and Frontotemporal Dementia With Parkinsonism
Arch Neurol, June 1, 2005; 62(6): 917 - 921.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. J. Whitworth, D. A. Theodore, J. C. Greene, H. Benes, P. D. Wes, and L. J. Pallanck
Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease
PNAS, May 31, 2005; 102(22): 8024 - 8029.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A F Wright
Neurogenetics II: complex disorders
J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 623 - 631.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. J. Montine and J. D. Morrow
Fatty Acid Oxidation in the Pathogenesis of Alzheimer's Disease
Am. J. Pathol., May 1, 2005; 166(5): 1283 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
H. Kolsch, M. Linnebank, D. Lutjohann, F. Jessen, U. Wullner, U. Harbrecht, K. M. Thelen, M. Kreis, F. Hentschel, A. Schulz, et al.
Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke
Neurology, December 28, 2004; 63(12): 2255 - 2260.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. Bertram and R. E. Tanzi
Alzheimer's disease: one disorder, too many genes?
Hum. Mol. Genet., April 1, 2004; 13(90001): R135 - 141.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.